Epigenetic codes in cognition and behaviour

Behavioural Brain Research

Volumn 192, Issue 1, 2008, Pages 70-87

  Gräff, Johannes ^a   Mansuy, Isabelle M ^a  

^a University of Zurich Brain Research Institute   (Switzerland)

Author keywords

Cognition; DNA methylation; Environment; Epigenetic mechanisms; Histone; Memory; Synaptic plasticity; Transgenerational inheritance

Indexed keywords

ADDICTION; ALZHEIMER DISEASE; BEHAVIOR; COGNITION; COGNITIVE DEFECT; DEPRESSION; DISEASE PREDISPOSITION; EPIGENETICS; EPILEPTOGENESIS; FRAGILE X SYNDROME; GENETIC PREDISPOSITION; GLUCOSE INTOLERANCE; HUMAN; HUNTINGTON CHOREA; LEARNING; LONGEVITY; MALE INFERTILITY; MEMORY; MORPHOLOGICAL TRAIT; MORTALITY; NEOPLASM; NERVE CELL PLASTICITY; NONHUMAN; OBESITY; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; RUBINSTEIN SYNDROME; SCHIZOPHRENIA; STRESS;

ANIMALS; BEHAVIOR; BRAIN; BRAIN CHEMISTRY; COGNITION; COGNITION DISORDERS; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURONAL PLASTICITY;

EID: 44649134044     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.01.021     Document Type: Review

References (149)

1. Waddington C.H. Organisers and genes (1940), Cambridge University Press, Cambridge
2. Waddington C.H. Canalization of development and the inheritance of acquired characters. Nature 150 (1942) 563-565
3. In: Russo V.E.A., Martienssen R.A., and Riggs A.D. (Eds). Epigenetic mechanisms of gene regulation (1996), Cold Spring Harbour Laboratory Press, Woodbury
4. Bird A. Perceptions of epigenetics. Nature 447 7143 (2007) 396-398
5. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 (2003) 245-254
6. Levenson J.M., and Sweatt J.D. Epigenetic mechanisms in memory formation. Nat Rev Neurosci 6 2 (2005) 108-118
7. Davey C.A., Sargent D.F., Luger K., Maeder A.W., and Richmond T.J. Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution. J Mol Biol 319 5 (2002) 1097-1113
8. Nathan D., Ingvarsdottir K., Sterner D.E., Bylebyl G.R., Dokmanovic M., Dorsey L.A., et al. Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Gene Dev 20 8 (2006) 966-976
9. Bird A. DNA methylation patterns and epigenetic memory. Gene Dev 16 1 (2002) 6-21
10. Klose R.J., and Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31 2 (2006) 89-97
11. Fan M., Yan P.S., Hartman-Frey C., Chen L., Paik H., Oyer S.L., et al. Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Res 66 24 (2006) 11954-11966
12. Weber M., Hellmann I., Stadler M.B., Ramos L., Paabo S., Rebhan M., et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39 4 (2007) 457-466
13. Brownell J.E., and Allis C.D. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev 6 2 (1996) 176-184
14. Klose R.J., and Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 8 4 (2007) 307-318
15. Peters A.H., and Schubeler D. Methylation of histones: playing memory with DNA. Curr Opin Cell Biol 17 2 (2005) 230-238
16. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 75 (2006) 243-269
17. Loury R., and Sassone-Corsi P. Histone phosphorylation: how to proceed. Methods 31 1 (2003) 40-48
18. He H., and Lehming N. Global effects of histone modifications. Brief Funct Genomic Proteomic 2 3 (2003) 234-243
19. Shiio Y., and Eisenman R.N. Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 100 23 (2003) 13225-13230
20. Kouzarides T. Chromatin modifications and their function. Cell 128 4 (2007) 693-705
21. Latham J.A., and Dent S.Y. Cross-regulation of histone modifications. Nat Struct Mol Biol 14 11 (2007) 1017-1024
22. Li B., Carey M., and Workman J.L. The role of chromatin during transcription. Cell 128 4 (2007) 707-719
23. Ruthenburg A.J., Allis C.D., and Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25 1 (2007) 15-30
24. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 5532 (2001) 1074-1080
25. Turner B.M. Cellular memory and the histone code. Cell 111 3 (2002) 285-291
26. Levenson J.M., and Sweatt J.D. Epigenetic mechanisms: a common theme in vertebrate and invertebrate memory formation. Cell Mol Life Sci 63 9 (2006) 1009-1016
27. Pittenger C., and Kandel E.R. In search of general mechanisms for long-lasting plasticity: Aplysia and the hippocampus. Philos Trans R Soc B 358 1432 (2003) 757-763
28. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294 5544 (2001) 1030-1038
29. Guan Z.H., Giustetto M., Lomvardas S., Kim J.H., Miniaci M.C., Schwartz J.H., et al. Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 111 4 (2002) 483-493
30. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 6407 (1993) 31-39
31. Bortolotto Z.A., and Collingridge G.L. Characterisation of LTP induced by the activation of glutamate metabotropic receptors in area CA1 of the hippocampus. Neuropharmacology 32 1 (1993) 1-9
32. Frey U., Matthies H., Reymann K.G., and Matthies H. The effect of dopaminergic D1 receptor blockade during tetanization on the expression of long-term potentiation in the rat CA1 region in vitro. Neurosci Lett 129 1 (1991) 111-114
33. Huerta P.T., and Lisman J.E. Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state. Nature 364 6439 (1993) 723-725
34. Crosio C., Heitz E., Allis C.D., Borrelli E., and Sassone-Corsi P. Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. J Cell Sci 116 Pt 24 (2003) 4905-4914
35. Sweatt J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76 1 (2001) 1-10
36. Levenson J.M., O'Riordan K.J., Brown K.D., Trinh M.A., Molfese D.L., and Sweatt J.D. Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 279 39 (2004) 40545-40559
37. Orlando V. Polycomb, epigenomes, and control of cell identity. Cell 112 5 (2003) 599-606
38. Kim S.Y., Levenson J.M., Korsmeyer S., Sweatt J.D., and Schumacher A. Developmental regulation of Eed complex composition governs a switch in global histone modification in brain. J Biol Chem 282 13 (2007) 9962-9972
39. Alarcon J.M., Malleret G., Touzani K., Vronskaya S., Ishii S., Kandel E.R., et al. Chromatin acetylation, memory, and LTP are impaired in CBP+/-mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 42 6 (2004) 947-959
40. Yeh S.H., Lin C.H., and Gean P.W. Acetylation of nuclear factor-kappa B in rat amygdala improves long-term but not short-term retention of fear memory. Mol Pharmacol 65 5 (2004) 1286-1292
41. Vecsey C.G., Hawk J.D., Lattal K.M., Stein J.M., Fabian S.A., Attner M.A., et al. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci 27 23 (2007) 6128-6140
42. Levenson J.M., Roth T.L., Lubin F.D., Miller C.A., Huang I.C., Desai P., et al. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 281 23 (2006) 15763-15773
43. Zhao X., Ueba T., Christie B.R., Barkho B., McConnell M.J., Nakashima K., et al. Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc Natl Acad Sci USA 100 11 (2003) 6777-6782
44. Huang Y., Doherty J.J., and Dingledine R. Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J Neurosci 22 19 (2002) 8422-8428
45. Tsankova N.M., Kumar A., and Nestler E.J. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci 24 24 (2004) 5603-5610
46. Crick F. Memory and molecular turnover. Nature 312 5990 (1984) 101
47. Holliday R. Is there an epigenetic component in long-term memory?. J Theor Biol 200 3 (1999) 339-341
48. Miller C.A., and Sweatt J.D. Covalent modification of DNA regulates memory formation. Neuron 53 6 (2007) 857-869
49. Swank M.W., and Sweatt J.D. Increased histone acetyltransferase and lysine acetyltransferase activity and biphasic activation of the ERK/RSK cascade in insular cortex during novel taste learning. J Neurosci 21 10 (2001) 3383-3391
50. Korzus E., Rosenfeld M.G., and Mayford M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42 6 (2004) 961-972
51. Oliveira A.M.M., Wood M.A., McDonough C.B., and Abel T. Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits. Learn Mem 14 (2007) 564-572
52. Cheung P., Allis C.D., and Sassone-Corsi P. Signaling to chromatin through histone modifications. Cell 103 2 (2000) 263-271
53. Chwang W.B., O'Riordan K.J., Levenson J.M., and Sweatt J.D. ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learn Mem 13 3 (2006) 322-328
54. Hedou G., and Mansuy I.M. Inducible molecular switches for the study of long-term potentiation. Philos Trans R Soc B 358 1432 (2003) 797-804
55. Bredy T.W., Wu H., Crego C., Zellhoefer J., Sun Y.E., and Barad M. Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 14 4 (2007) 268-276
56. Petrij F., Giles R.H., Dauwerse H.G., Saris J.J., Hennekam R.C., Masuno M., et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376 6538 (1995) 348-351
57. Roelfsema J.H., White S.J., Ariyurek Y., Bartholdi D., Niedrist D., Papadia F., et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 76 4 (2005) 572-580
58. Kalkhoven E., Roelfsema J.H., Teunissen H., den Boer A., Ariyurek Y., Zantema A., et al. Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome. Hum Mol Genet 12 4 (2003) 441-450
59. Murata T., Kurokawa R., Krones A., Tatsumi K., Ishii M., Taki T., et al. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum Mol Genet 10 10 (2001) 1071-1076
60. Bourtchouladze R., Lidge R., Catapano R., Stanley J., Gossweiler S., Romashko D., et al. A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4. Proc Natl Acad Sci USA 100 18 (2003) 10518-10522
61. Oike Y., Hata A., Mamiya T., Kaname T., Noda Y., Suzuki M., et al. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum Mol Genet 8 3 (1999) 387-396
62. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., and Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23 2 (1999) 185-188
63. Chen R.Z., Akbarian S., Tudor M., and Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27 3 (2001) 327-331
64. Guy J., Hendrich B., Holmes M., Martin J.E., and Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27 3 (2001) 322-326
65. Collins A.L., Levenson J.M., Vilaythong A.P., Richman R., Armstrong D.L., Noebels J.L., et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13 21 (2004) 2679-2689
66. Zhou Z., Hong E.J., Cohen S., Zhao W.N., Ho H.Y., Schmidt L., et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52 2 (2006) 255-269
67. Martinowich K., Hattori D., Wu H., Fouse S., He F., Hu Y., et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302 5646 (2003) 890-893
68. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302 5646 (2003) 885-889
69. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35 2 (2002) 243-254
70. Hong E.J., West A.E., and Greenberg M.E. Transcriptional control of cognitive development. Curr Opin Neurobiol 15 1 (2005) 21-28
71. Ashley C.T., Sutcliffe J.S., Kunst C.B., Leiner H.A., Eichler E.E., Nelson D.L., et al. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet 4 3 (1993) 244-251
72. Gecz J., Gedeon A.K., Sutherland G.R., and Mulley J.C. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet 13 1 (1996) 105-108
73. Gu Y., Shen Y., Gibbs R.A., and Nelson D.L. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat Genet 13 1 (1996) 109-113
74. Gu Y., McIlwain K.L., Weeber E.J., Yamagata T., Xu B., Antalffy B.A., et al. Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. J Neurosci 22 7 (2002) 2753-2763
75. Tabolacci E., Pietrobono R., Moscato U., Oostra B.A., Chiurazzi P., and Neri G. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Eur J Hum Genet 13 5 (2005) 641-648
76. Cummings J.L. Alzheimer's disease. N Engl J Med 351 1 (2004) 56-67
77. Cao X., and Sudhof T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293 5527 (2001) 115-120
78. Marambaud P., Wen P.H., Dutt A., Shioi J., Takashima A., Siman R., et al. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114 5 (2003) 635-645
79. Rouaux C., Jokic N., Mbebi C., Boutillier S., Loeffler J.P., and Boutillier A.L. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 22 24 (2003) 6537-6549
80. Saura C.A., Choi S.Y., Beglopoulos V., Malkani S., Zhang D., Shankaranarayana Rao B.S., et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42 1 (2004) 23-36
81. Scarpa S., Fuso A., D'Anselmi F., and Cavallaro R.A. Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease?. FEBS Lett 541 1-3 (2003) 145-148
82. Scarpa S., Cavallaro R.A., D'Anselmi F., and Fuso A. Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. J Alzheimer's Dis 9 4 (2006) 407-414
83. Bates G.P. History of genetic disease: the molecular genetics of Huntington disease - a history. Nat Rev Genet 6 10 (2005) 766-773
84. Steffan J.S., Bodai L., Pallos J., Poelman M., McCampbell A., Apostol B.L., et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413 6857 (2001) 739-743
85. Ferrante R.J., Kubilus J.K., Lee J., Ryu H., Beesen A., Zucker B., et al. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23 28 (2003) 9418-9427
86. Hockly E., Richon V.M., Woodman B., Smith D.L., Zhou X., Rosa E., et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci USA 100 4 (2003) 2041-2046
87. Gardian G., Browne S.E., Choi D.K., Klivenyi P., Gregorio J., Kubilus J.K., et al. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem 280 1 (2005) 556-563
88. Tsankova N., Renthal W., Kumar A., and Nestler E.J. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8 5 (2007) 355-367
89. Costa E., Chen Y., Davis J., Dong E., Noh J.S., Tremolizzo L., et al. REELIN and Schizophrenia: a disease at the interface of the genome and the epigenome. Mol Interv 2 1 (2002) 47-57
90. Chen Y., Sharma R.P., Costa R.H., Costa E., and Grayson D.R. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res 30 13 (2002) 2930-2939
91. Tremolizzo L., Carboni G., Ruzicka W.B., Mitchell C.P., Sugaya I., Tueting P., et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci USA 99 26 (2002) 17095-17100
92. Dong E., Agis-Balboa R.C., Simonini M.V., Grayson D.R., Costa E., and Guidotti A. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci USA 102 35 (2005) 12578-12583
93. Grayson D.R., Chen Y., Costa E., Dong E., Guidotti A., Kundakovic M., et al. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (±) in schizophrenia. Pharmacol Ther 111 1 (2006) 272-286
94. Kumar A., Choi K.H., Renthal W., Tsankova N.M., Theobald D.E.H., Truong H.T., et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48 2 (2005) 303-314
95. Brami-Cherrier K., Valjent E., Herve D., Darragh J., Corvol J.C., Pages C., et al. Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice. J Neurosci 25 49 (2005) 11444-11454
96. Levine A.A., Guan Z., Barco A., Xu S., Kandel E.R., and Schwartz J.H. CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci USA 102 52 (2005) 19186-19191
97. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., and Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 23 3 (2003) 742-747
98. Bibb J.A., Chen J., Taylor J.R., Svenningsson P., Nishi A., Snyder G.L., et al. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410 6826 (2001) 376-380
99. Cassel S., Carouge D., Gensburger C., Anglard P., Burgun C., Dietrich J.B., et al. Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 70 2 (2006) 487-492
100. Kim J.S., and Shukla S.D. Acute in vivo effect of ethanol (binge drinking) on histone H3 modifications in rat tissues. Alcohol Alcohol 41 2 (2006) 126-132
101. Bonsch D., Lenz B., Kornhuber J., and Bleich S. DNA hypermethylation of the alpha synuclein promoter in patients with alcoholism. Neuroreport 16 2 (2005) 167-170
102. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., and Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9 4 (2006) 519-525
103. Schroeder F.A., Lin C.L., Crusio W.E., and Akbarian S. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62 1 (2007) 55-64
104. Lee M.G., Wynder C., Schmidt D.M., McCafferty D.G., and Shiekhattar R. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 13 6 (2006) 563-567
105. Champagne F.A., Francis D.D., Mar A., and Meaney M.J. Variations in maternal care in the rat as a mediating influence for the effects of environment on development. Physiol Behav 79 3 (2003) 359-371
106. Meaney M.J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 24 (2001) 1161-1192
107. Francis D., Diorio J., Liu D., and Meaney M.J. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 286 5442 (1999) 1155-1158
108. Weaver I.C.G., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., et al. Epigenetic programming by maternal behavior. Nat Neurosci 7 8 (2004) 847-854
109. Liu D., Diorio J., Tannenbaum B., Caldji C., Francis D., Freedman A., et al. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277 5332 (1997) 1659-1662
110. Weaver I.C., D'Alessio A.C., Brown S.E., Hellstrom I.C., Dymov S., Sharma S., et al. The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J Neurosci 27 7 (2007) 1756-1768
111. Weaver I.C.G., Champagne F.A., Brown S.E., Dymov S., Sharma S., Meaney M.J., et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 25 47 (2005) 11045-11054
112. Weaver I.C., Meaney M.J., and Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA 103 9 (2006) 3480-3485
113. Bilang-Bleuel A., Ulbricht S., Chandramohan Y., De Carli S., Droste S.K., and Reul J.M.H.M. Psychological stress increases histone H3 phosphorylation in adult dentate gyrus granule neurons: involvement in a glucocorticoid receptor-dependent behavioural response. Eur J Neurosci 22 7 (2005) 1691-1700
114. Molinier J., Ries G., Zipfel C., and Hohn B. Transgeneration memory of stress in plants. Nature 442 7106 (2006) 1046-1049
115. Xing Y., Shi S., Le L., Lee C.A., Silver-Morse L., and Li W.X. Evidence for transgenerational transmission of epigenetic tumor susceptibility in Drosophila. PLoS Genet 3 9 (2007) e151
116. Chong S.Y., and Whitelaw E. Epigenetic germline inheritance. Curr Opin Genet Dev 14 6 (2004) 692-696
117. Richards E.J. Opinion - inherited epigenetic variation - revisiting soft inheritance. Nat Rev Genet 7 5 (2006) 395-402
118. Rakyan V.K., Preis J., Morgan H.D., and Whitelaw E. The marks, mechanisms and memory of epigenetic states in mammals. Biochem J 356 (2001) 1-10
119. Morgan H.D., Sutherland H.G., Martin D.I., and Whitelaw E. Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 23 3 (1999) 314-318
120. Wolff G.L., Kodell R.L., Moore S.R., and Cooney C.A. Maternal epigenetics and methyl supplements affect agouti gene expression in A(vy)/a mice. FASEB J 12 11 (1998) 949-957
121. Waterland R.A., and Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23 15 (2003) 5293-5300
122. Cooney C.A., Dave A.A., and Wolff G.L. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 132 Suppl. 8 (2002) 2393S-400S
123. vy allele by nutritional supplementation. Proc Natl Acad Sci USA 103 46 (2006) 17308-17312
124. Vasicek T.J., Zhen L., Guan X.-J., Zhang T., Costantini F., and Tilghman S.M. Two dominant mutations in the mouse fused gene are the result of transposon insertions. Genetics 147 2 (1997) 777-786
125. Rakyan V.K., Chong S., Champ M.E., Cuthbert P.C., Morgan H.D., Luu K.V., et al. Transgenerational inheritance of epigenetic states at the murine Axin(Fu) allele occurs after maternal and paternal transmission. Proc Natl Acad Sci USA 100 5 (2003) 2538-2543
126. Liu Y. Like father like son. EMBO Rep 8 9 (2007) 798-803
127. Jirtle R.L., and Skinner M.K. Environmental epigenomics and disease susceptibility. Nat Rev Genet 8 4 (2007) 253-262
128. Dolinoy D.C., Weidman J.R., Waterland R.A., and Jirtle R.L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114 4 (2006) 567-572
129. Anderson C.M., Lopez F., Zimmer A., and Benoit J.N. Placental insufficiency leads to developmental hypertension and mesenteric artery dysfunction in two generations of Sprague-Dawley rat offspring. Biol Reprod 74 3 (2006) 538-544
130. Zambrano E., Martinez-Samayoa P.M., Bautista C.J., Deas M., Guillen L., Rodriguez-Gonzalez G.L., et al. Sex differences in transgenerational alterations of growth and metabolism in progeny (F2) of female offspring (F1) of rats fed a low protein diet during pregnancy and lactation. J Physiol 566 Pt 1 (2005) 225-236
131. Anway M.D., Cupp A.S., Uzumcu M., and Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308 5727 (2005) 1466-1469
132. Anway M.D., Leathers C., and Skinner M.K. Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology 147 12 (2006) 5515-5523
133. Chang H.S., Anway M.D., Rekow S.S., and Skinner M.K. Transgenerational epigenetic imprinting of the male germline by endocrine disruptor exposure during gonadal sex determination. Endocrinology 147 12 (2006) 5524-5541
134. Chen T.H.H., Chiu Y.H., and Boucher B.J. Transgenerational effects of betel-quid chewing on the development of the metabolic syndrome in the Keelung Community-based Integrated Screening Program. Am J Clin Nutr 83 3 (2006) 688-692
135. Boucher B.J., Ewen S.W.B., and Stowers J.M. Betel Nut (Areca catechu) consumption and the induction of glucose-intolerance in adult Cd1 mice and in their F1 and F2 offspring. Diabetologia 37 1 (1994) 49-55
136. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 16 (2007) R50-R59 Spec. No. 1
137. Chan T.L., Yuen S.T., Kong C.K., Chan Y.W., Chan A.S.Y., Ng W.F., et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 38 10 (2006) 1178-1183
138. Hitchins M.P., Wong J.J., Suthers G., Suter C.M., Martin D.I., Hawkins N.J., et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med 356 7 (2007) 697-705
139. Hitchins M.P., and Ward R.L. Erasure of MLH1 methylation in spermatozoa-implications for epigenetic inheritance. Nat Genet 39 11 (2007) 1289
140. Suter C.M., Martin D.I., and Ward R.L. Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 36 5 (2004) 497-501
141. Suter C.M., Martin D.I., and Ward R.L. Addendum: Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 39 11 (2007) 1414
142. Kaati G., Bygren L.O., and Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur J Hum Genet 10 11 (2002) 682-688
143. Kaati G., Bygren L.O., Pembrey M., and Sjostrom M. Transgenerational response to nutrition, early life circumstances and longevity. Eur J Hum Genet 15 7 (2007) 784-790
144. Pembrey M.E., Bygren L.O., Kaati G., Edvinsson S., Northstone K., Sjostrom M., et al. Sex-specific, male-line transgenerational responses in humans. Eur J Hum Genet 14 2 (2006) 159-166
145. Alberini C.M., Milekic M.H., and Tronel S. Mechanisms of memory stabilization and de-stabilization. Cell Mol Life Sci 63 9 (2006) 999-1008
146. Guenther M.G., Levine S.S., Boyer L.A., Jaenisch R., and Young R.A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130 1 (2007) 77-88
147. Jablonka E., and Lamb M.J. Epigenetic inheritance in evolution. J Evolution Biol 11 2 (1998) 159-183
148. Cavalli G., and Paro R. Epigenetic inheritance of active chromatin after removal of the main transactivator. Science 286 5441 (1999) 955-958
149. Gerken T., Girard C.A., Loraine Tung Y.-C., Webby C.J., Saudek V., Hewitson K.S., et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318 5855 (2007) 1469-1472